Asthma happens when your immune system overreacts to normally harmless triggers, causing the airways in your lungs to narrow in three simultaneous ways: the muscles around the airways tighten, the airway lining swells with inflammation, and cells produce excess mucus that clogs the remaining space. An estimated 363 million people worldwide had asthma in 2023, and the condition caused 442,000 deaths that year. Understanding the chain of events inside your lungs helps explain why asthma feels the way it does and why it behaves differently from person to person.
What Happens Inside Your Airways
Your airways are tubes lined with smooth muscle, a thin layer of tissue, and mucus-producing cells. In a healthy lung, these components work quietly together, keeping the tubes open and trapping small particles in a thin layer of mucus that gets swept out. In asthma, the immune system treats certain substances (allergens, cold air, pollution) as threats and launches an inflammatory response that disrupts all three of these structures at once.
The first and fastest change is bronchoconstriction. The smooth muscle bands that wrap around your airways contract sharply, squeezing the tubes to a fraction of their normal diameter. This is what produces that tight, constricted feeling in your chest and the characteristic wheeze as air forces its way through a narrowed opening.
At the same time, the tissue lining the airways swells as fluid leaks from blood vessels into the surrounding tissue. This edema further reduces the space available for air to flow. On top of that, goblet cells (the mucus-producing cells in the airway lining) multiply and overproduce a thick, sticky mucus. Research published in the Journal of Clinical Investigation found that mucus-plugged airways in asthma show significantly higher numbers of both goblet cells and the rapidly dividing basal cells that generate them. The result is plugs of mucus that can physically block smaller airways, trapping air in parts of the lung and making it especially hard to exhale.
The Immune Response Behind It
The inflammation driving asthma isn’t random. In the most common form, allergic asthma, the process starts when your immune system encounters an allergen like dust mites, pollen, or pet dander. Specialized immune cells called T-helper 2 (Th2) cells coordinate the response, signaling other cells to join the fight. B cells produce an antibody called IgE, which attaches to mast cells sitting in the airway tissue. The next time that allergen appears, IgE recognizes it and triggers the mast cells to release a burst of chemicals, including histamine, that cause immediate muscle tightening and swelling.
Eosinophils, a type of white blood cell, are recruited to the airways in large numbers. They release toxic proteins meant to kill parasites but in this context damage the delicate airway lining instead. This cellular assault is what sustains inflammation between flare-ups and why asthma is considered a chronic condition, not just a series of isolated attacks. Even when you feel fine, low-grade inflammation may be simmering in your airways.
Not All Asthma Works the Same Way
Roughly half of people with asthma have what researchers call “T2-high” asthma, driven by the eosinophil-heavy, IgE-mediated immune pathway described above. This type typically starts in childhood, is linked to allergies, and tends to respond well to standard treatments like inhaled corticosteroids.
The other major category, “T2-low” asthma, is less well understood. It lacks the hallmark eosinophilic inflammation and doesn’t respond as reliably to corticosteroids. Instead, it may involve different immune pathways, including neutrophil-driven inflammation or mechanisms tied to obesity and metabolic dysfunction. This helps explain why some people with asthma find that standard inhalers don’t control their symptoms well. Their underlying biology is genuinely different.
What Causes Asthma to Develop
Asthma doesn’t have a single cause. It emerges from a collision of genetic predisposition and environmental exposure. Genome-wide studies have identified a reproducible set of genetic variants that raise asthma risk, including specific gene interactions (such as between CDHR3 and GSDMB) linked to early and severe childhood asthma. But genes alone aren’t destiny. They load the gun; environment pulls the trigger.
Four modifiable risk factors account for nearly 30% of the global disease burden from asthma: high BMI, occupational exposures (chemicals, dust, fumes), traffic-related air pollution, and smoking. Prenatal and postnatal secondhand smoke exposure is an established risk factor for childhood-onset asthma, with emerging evidence extending that risk to e-cigarettes.
Early life microbial exposure also plays a significant role. The hygiene hypothesis suggests that a child’s microbial environment in the first months of life is essential for training the immune system to tolerate harmless substances rather than attacking them. Studies have found that infants exposed to certain bacterial components (like endotoxin) had less allergic sensitization and less asthma by school age. One study even found that children whose parents cleaned pacifiers by putting them in their own mouths, transferring oral bacteria to the child, were less likely to develop allergic sensitization and eczema by 18 months. The pattern is consistent: early microbial diversity appears to steer the immune system away from the overreactive responses that underlie asthma.
Common Triggers and How They Work
Once asthma is established, a wide range of triggers can set off a flare-up. Allergens like pollen, mold, dust mites, and animal dander activate the IgE pathway directly. Respiratory infections, especially viral ones, inflame airways that are already primed to overreact. Cold air, strong emotions, and certain medications can all provoke bronchoconstriction through different mechanisms.
Exercise is one of the most common triggers, and it works through a specific physical process. When you breathe hard during exertion, you lose water and heat from the airway surface faster than your body can replace them. This cooling and dehydration of the airway lining triggers the release of chemicals like histamine and leukotrienes, which cause the surrounding smooth muscle to contract. There’s also a thermal rebound effect: blood vessels in the airway walls first constrict from the cold, then rapidly dilate as the airways rewarm, causing fluid to leak into the tissue and produce swelling. This is why symptoms often peak five to ten minutes after you stop exercising rather than during the activity itself.
What Happens Over Time
If airway inflammation persists without adequate control, the airways undergo permanent structural changes known as remodeling. The tissue beneath the airway lining thickens and develops fibrosis, essentially scarring. The smooth muscle mass increases, making the airways more prone to tightening. New blood vessels grow into the airway walls, and the mucus-producing goblet cells remain in an overactive state. The airway lining itself changes character, with normal cells replaced by types better suited to mucus production than gas exchange.
These changes are not fully reversible. Remodeled airways are stiffer, narrower at baseline, and less responsive to bronchodilator medications. This is a key reason why consistent management matters even during symptom-free periods. The goal isn’t just to stop wheezing in the moment but to keep the underlying inflammation low enough to prevent the slow accumulation of structural damage that makes asthma progressively harder to control over years and decades.